Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Contact Us
    • Locations

Breadcrumb

  1. Emmes Group

Safety of kidney biopsy in pediatric transplantation: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS),

Go back to Resources

Safety of kidney biopsy in pediatric transplantation: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS),

Authors:

Location:

Go back to Resources

Safety and immunogenicity of env 2-3, a human immunodeficiency virus type 1 candidate vaccine, in combination with a novel adjuvant, MTP-PE/MF59,

Go back to Resources

Safety and immunogenicity of env 2-3, a human immunodeficiency virus type 1 candidate vaccine, in combination with a novel adjuvant, MTP-PE/MF59,

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Safety and immunogenicity of a candidate HIV-1 vaccine in healthy adults: recombinant glycoprotein (rgp) 120,

Go back to Resources

Safety and immunogenicity of a candidate HIV-1 vaccine in healthy adults: recombinant glycoprotein (rgp) 120,

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Risk factors for vascular thrombosis in pediatric renal transplantation: a special report of the North American Pediatric Renal Transplant Cooperative Study,

Go back to Resources

Risk factors for vascular thrombosis in pediatric renal transplantation: a special report of the North American Pediatric Renal Transplant Cooperative Study,

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Risk factors for vascular thrombosis (VT) in pediatric renal transplantation,

Go back to Resources

Risk factors for vascular thrombosis (VT) in pediatric renal transplantation,

Authors:

Location:

Go back to Resources

Risk factors for preeclampsia in healthy nulliparous women.

Go back to Resources

Risk factors for preeclampsia in healthy nulliparous women.

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Risk factors for preeclampsia in healthy nulliparous women,

Go back to Resources

Risk factors for preeclampsia in healthy nulliparous women,

Authors:

Location:

Go back to Resources

Risk factors for mortality in infants and young children on dialysis: A report of the North American Renal Transplant Cooperative Study (NAPRTCS),

Go back to Resources

Risk factors for mortality in infants and young children on dialysis: A report of the North American Renal Transplant Cooperative Study (NAPRTCS),

Authors:

Location:

Go back to Resources

Report on the standardization of clonogeneic hematopoietic precursor assays for the NHLBI Unrelated Donor Bone Marrow Transplantation Trial,

Go back to Resources

Report on the standardization of clonogeneic hematopoietic precursor assays for the NHLBI Unrelated Donor Bone Marrow Transplantation Trial,

Authors:

Go back to Resources

Report on the Standardization of Clonogeneic Hematopoietic Precursor Assays for the NHLBI Unrelated Donor Bone Marrow Transplant Trial,

Go back to Resources

Report on the Standardization of Clonogeneic Hematopoietic Precursor Assays for the NHLBI Unrelated Donor Bone Marrow Transplant Trial,

Authors:

Location:

Go back to Resources

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 109
  • Page 110
  • Page 111
  • Page 112
  • Current page 113
  • Page 114
  • Page 115
  • Page 116
  • Page 117
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Contact Us
    • Locations
linkedin X

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions
  • Terms of Use
  • ISO Certification